Welcome to the CATH PCI Registries Educational Overview. This content and presentation was developed and is narrated by Cornelia Anderson. The objectives for this registry overview are for the learner to be able to define the purpose and background of the CATH PCI Registry and the role of registry governance, identify the significance of coronary artery disease, discuss the specific scope and inclusion population. The CATH PCI Registry was designed to assess the characteristics, treatments, and outcomes of patients with coronary artery disease who undergo diagnostic and interventional cardiac catheterization procedures. Patient-level data is submitted by participating hospitals on a quarterly basis, so they might receive registry feedback that helps them optimize the outcomes and management of patients with coronary artery disease, also known as CAD, through the implementation of evidence-based guideline recommendations. Registry reports provide hospitals feedback in a variety of metrics that can support a hospital's internal process and quality improvement efforts. These include, but are not limited to, appropriate use criteria, PCI process and PCI outcomes information, and risk-adjusted benchmark data. The secondary aim of the CATH PCI Registry is to serve as a rich source of data providing opportunities for comparative effectiveness research. The registry inclusion criteria is specific to adult patients who are greater than or equal to 18 years of age, who have a diagnostic coronary angiography, and or percutaneous coronary intervention, or PCI procedure. The CATH PCI Registry was launched in 1998 to assess patient and procedural outcomes after PCI. This low-cost, low-risk, alternative treatment to coronary artery bypass graft surgery for patients with obstructive CAD was quickly adopted by hospitals across the country. Voluntarily, centers performing PCI joined the CATH PCI Registry and have continued to participate since its launch. Today, approximately 98% of the market share of CATH labs participate in the registry, and the number of international sites increases annually. The registry includes over 13 million diagnostic and 9 million PCI records accumulated between 1998 and 2017. This presents a wealth of data to support knowledge growth surrounding our unique patient and procedure population. The Center for Disease Control provides that 370,000 people die annually from CAD and 735,000 people will have a heart attack. The primary treatment recommended for patients having a heart attack is timely PCI. As a nationally recognized surveillance tool, the CATH PCI Registry is well-positioned within the healthcare industry and provides participants weekly access to their data and metric performance through an interactive dashboard and quarterly benchmark feedback through the published outcomes report. These data support ongoing quality improvement efforts by hospitals performing this lifesaving intervention. The CATH PCI Registry has also become a tool for outside stakeholders, healthcare systems, states and payers who use it to assess the incidence and trends of PCI procedures and the quality of care given by providers and the centers engaged in performing these procedures. It supports numerous research initiatives, informs clinical practice, and guideline development. Additionally, registry data can be used to support ACC accreditation services, CATH lab accreditation, and select metrics have been developed for public reporting. Hospitals who engage in public reporting will receive credit towards their score for ranking with the U.S. News and World Report's Best Hospitals in Cardiology and Heart Surgery, and their data will appear on the ACC's publicly facing website, CardioSmart, designed to support patient knowledge. The CATH PCI Registry is governed by a seven to 10-member steering committee with a chair and a representative from the Society for Cardiovascular Angiography and Interventions Member Society and ex-officio members from the CATH PCI Registry Research and Publication Subcommittee and NCDR Management Board. Committee members have expertise in clinical practice, financial management, quality measurement and improvement, and or health system strategy and innovation. The steering committee provides strategic oversight and direction of the registry, guidance for program activities, and helps identify and prioritize research initiatives. Committee recommendations are provided to the NCDR Management Board, thus helping to inform and influence the direction of the NCDR. This concludes the overview of the CATH PCI Registry. Thank you for your participation. www.cdc.gov.au

CATH PCI Registry

coronary artery disease

cardiac catheterization procedures

patient outcomes

quality improvement